[494] EARLY HBV-DNA SUPPRESSION DURING TREATMENT WITH LAMIVUDINE FOR HBeAg NEGATIVE CHRONIC HEPATITIS B LEADS TO MAINTENANCE OF RESPONSE UNDER TREATMENT von Hadziyannis, A.S, Hadzivannis, S.J

Volltext

[60] HBV cecDNA, PREGENOMIC RNA AND TOTAL HBVDNA LEVELS IN THE LIVER OF HBeAg-NEGATIVE CHB PATIENTS UNDER LONG TERM ANTIVIRAL THERAPY von Laras, A, Kostamena, A, Hadzivannis, S.J

Volltext

611 Poor prognostic factors in heavier patients with chronic hepatitis C (CHC) result in less favourable treatment outcomes von Swain, M.G., Foster, G.R., Hadzivannis, S.J., Heathcote, E.J., Jensen, D., Lee, S.S., Pockros, P.J., Sulkowski, M., Reddys, R., Trepo, C.

Volltext

Anti-HCV C100-3 prevalence and titers in chronic NANB hepatitis before and after a-interferon treatment von Hadziyanni, E., Alexopoulou, A., Bramou, T., Psalidaki, E., Hadzivannis, S.J.

Volltext